ZNTL

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Zentalis Pharmaceuticals (ZNTL) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

ZNTL is expected to report earnings to fall 26.64% to -90 cents per share on November 15

Zentalis Pharmaceuticals ZNTL Stock Earnings Reports

Q3'24

Est.

$-0.91

Q2'24

Missed

by $0.40

Q1'24

Beat

by $0.91

Q4'23

Est.

$-0.86

Q3'23

Beat

by $0.13

The last earnings report on August 09 showed earnings per share of -124 cents, missing the estimate of -84 cents. With 898.01K shares outstanding, the current market capitalization sits at 280.88M.

View a ticker or compare two or three

Compare

ZNTL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ZNTL
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ZNTL (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company, which focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1359 Broadway

Phone

+1 212 433-3791

Employees

168

Web

https://www.zentalis.com